case_images: PMC10601765_01
case_images: Target-like skin rash the day after the second IVIG administration.
case_images: cde-2023-0015-0001-533987_F01.jpg
case_images: PMC10601765_01_cde-2023-0015-0001-533987_F01.jpg
case_images: F1
case_images: In some places, there were blisters of varying diameters with serous content that were tense and did not burst spontaneously (Fig. 1).
case_images: Skin rash after therapy course in the hospital.
case_images: cde-2023-0015-0001-533987_F02.jpg
case_images: PMC10601765_01_cde-2023-0015-0001-533987_F02.jpg
case_images: F2
case_images: After undergoing a course of oral glucocorticoid therapy, an improvement in the patient's skin condition was observed and the skin elements continued to regress (Fig. 2).
case_images: Erythema exsudativum multiforme, histological image (dermoepidermal type).
case_images: cde-2023-0015-0001-533987_F03.jpg
case_images: PMC10601765_01_cde-2023-0015-0001-533987_F03.jpg
case_images: F3
case_images: In the dermis, there is a pericapillary lymphohistiocytic infiltrate with eosinophil leukocytes and lymphocytes in the interstitium (Fig. 3).